Experts call for significant changes to facilitate the discovery of new treatments.

Novel digital platform for clinical trial data collection could help facilitate much-needed biomedical research in lower-income countries.

Great progress has been made against malaria, but signs of resistance are becoming a rising concern

Novartis is collaborating with Microsoft to apply machine learning to medicinal chemistry — part of an effort to leverage AI to bring treatments to patients more efficiently.

Researchers race to put hydroxychloroquine to the test in a large study.

Hear from Director of Patient Services at AAMDSIF on how she supports patients with PNH, a blood disorder that significantly impacts quality of life.

This moving personal story about the challenges of living with a rare disease is written by Rocco Falchetto, a biochemist and director of analytical sciences and imaging at the Novartis Institutes for BioMedical Research (NIBR).

Receiving a breast cancer diagnosis is difficult, but these young women faced an especially challenging diagnosis: stage IV metastatic breast cancer.